UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control

Diabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1305-1310

2019

Volltextzugriff (PDF)

Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100 U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy

Diabetes research and clinical practice, 2017-02

2017

Volltextzugriff (PDF)

When basal insulin is not enough: response to M Davidson

Diabetes, obesity & metabolism, 2020-04, Vol.22 (4), p.711-712

2020

Volltextzugriff (PDF)

Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials

Diabetes research and clinical practice, 2014-11, Vol.106 (2), p.264-274

2014

Volltextzugriff (PDF)

Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100 U/mL versus neutral protamine Hagedorn insulin: an exploration of key predictors from two randomized controlled trials

Journal of diabetes and its complications, 2017-03, Vol.31 (3), p.562-568

2017

Volltextzugriff (PDF)

Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy

Diabetes research and clinical practice, 2017-02, Vol.124, p.57-65

2017

Volltextzugriff (PDF)

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat‐to‐target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes

Diabetes, obesity & metabolism, 2017-11, Vol.19 (11), p.1546-1554

2017

Volltextzugriff (PDF)

Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes

Diabetes technology & therapeutics, 2014-02, Vol.16 (2), p.76-83

2014

Volltextzugriff (PDF)

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat‐to‐target trials with insulin glargine 100U/mL added to oral antidiabetes agents in type 2 diabetes

Diabetes, obesity & metabolism, 2017-11, Vol.19 (11), p.1546-1554

2017

Volltextzugriff (PDF)

Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials

Journal of diabetes and its complications, 2017-03, Vol.31 (3), p.562-568

2017

Volltextzugriff (PDF)

Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty

Anesthesiology (Philadelphia), 2003-04, Vol.98 (4), p.950-956

2003

Volltextzugriff (PDF)

Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus

Endocrine practice, 2010-07, Vol.16 (4), p.588-599

2010

Volltextzugriff (PDF)

9. Effects of Metformin and Sulfonylurea on Efficacy and Hypoglycemia After Addition of Insulin Glargine or NPH in T2DM - View session detail (928-P)

Nederlands Tijdschrift voor Diabetolog, 2014-10, Vol.12 (4), p.13-13

2014

Volltextzugriff (PDF)

Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes

Postgraduate medicine, 2016-11, Vol.128 (8), p.731-739

2016

Volltextzugriff (PDF)

A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy

American journal of obstetrics and gynecology, 2004-10, Vol.191 (4), p.1183-1191

2004

Volltextzugriff (PDF)

A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes

European endocrinology, 2014-02, Vol.10 (1), p.23-30

2014

Volltextzugriff (PDF)

Analgesic efficacy of preoperative parecoxib sodium in an orthopedic pain model

Journal of the American Podiatric Medical Association, 2004-05, Vol.94 (3), p.305-314

2004

Volltextzugriff (PDF)

Simulation of rare queueing events by switching arrival and service rates

Proceedings of the 25th conference on Winter simulation, 1993, p.317-322

1993

Volltextzugriff (PDF)

Millimeter wave radiation to measure blood flow in healthy human subjects

Physiological measurement, 2024-09

2024

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(18)
Tagungsberichte
(1)

Sprache

Englisch
(18)
Niederländisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control

Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100 U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy

When basal insulin is not enough: response to M Davidson

Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials

Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100 U/mL versus neutral protamine Hagedorn insulin: an exploration of key predictors from two randomized controlled trials

Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat‐to‐target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes

Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat‐to‐target trials with insulin glargine 100U/mL added to oral antidiabetes agents in type 2 diabetes

Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials

Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty

Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus

9. Effects of Metformin and Sulfonylurea on Efficacy and Hypoglycemia After Addition of Insulin Glargine or NPH in T2DM - View session detail (928-P)

Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes

A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy

A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes

Analgesic efficacy of preoperative parecoxib sodium in an orthopedic pain model

Simulation of rare queueing events by switching arrival and service rates

Millimeter wave radiation to measure blood flow in healthy human subjects

Suchergebnisse filtern